Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
175 hedge funds and large institutions have $650M invested in Intercept Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 52 reducing their positions, and 37 closing their positions.
12% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 52
5% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 37
1% less funds holding
Funds holding: 177 → 175 (-2)
25% less call options, than puts
Call options by funds: $36M | Put options by funds: $47.8M
45% less capital invested
Capital invested by funds: $1.18B → $650M (-$528M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$28.5M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$14.8M |
| 3 |
Goldman Sachs
New York
|
+$11.7M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$11.6M |
| 5 |
BlackRock
New York
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$48.8M |
| 2 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$39.8M |
| 3 |
SM
Senvest Management
New York
|
-$32.4M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$23.1M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$11M |
ICPT Hedge Fund Activity: Q4 2020 in Review
175 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q4 2020, worth a combined $650M — down 45% from $1.18B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of ICPT and 35 opened new positions — a net loss of 2 holders — while 52 trimmed existing stakes and 58 added.
The largest buyer was State Street, adding an estimated $28.5M. The largest seller was Boxer Capital, exiting entirely with an estimated $48.8M sold.
- 175 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q4 2020, down from 177 in Q3 2020.
- Funds reported $650M of Intercept Pharmaceuticals, Inc. stock for Q4 2020, down 45% quarter-over-quarter.
- 35 funds opened new Intercept Pharmaceuticals, Inc. positions in Q4 2020 and 37 closed out, a net change of -2 holders.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q4 2020 was State Street, an estimated $28.5M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q4 2020 was Boxer Capital, an estimated $48.8M sold.
Based on aggregated 13F filings for Q4 2020.